Sperogenix
曙方
SperogenixCompany
曙方
No graph yet
Mentioned in 3 articles
Coverage
Over $1.2 Billion in Total Value: Triastek Announces First-Ever Technology Platform International Collaboration in Chinese Pharmaceutical History with BioNTech | Yunqi Capital
Empowering Digital Transformation in Pharmaceutical Development
云启资本·"Triastek" Closes 150 Million Yuan Pre-C Round to Accelerate Commercialization of 3D-Printed Drugs | Yunqi Capital
Pioneering a New Era of Intelligent Drug Discovery
云启资本·How Can a "3D Printer" Boost Productivity in the Pharmaceutical Industry? | The B-Side of Entrepreneurship
Take the hard, meaningful path
云启资本·
